|
Differentiating the Invasiveness of Lung Adenocarcinoma by Dual Energy CT Parameter
RECRUITINGSponsored by Tang-Du Hospital
Actively Recruiting
SponsorTang-Du Hospital
Started2024-06-01
Est. completion2025-12-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06441357
Summary
The core purpose of this study is to investigate whether the extracellular volume (ECV) fraction measured in delay phase by dual energy computed tomography (DECT) can distinguish precancerous lesions from early-stage lung adenocarcinomas, which could assist clinical decision making for surgery operation indication and strategy.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * patients older than 18 years old with pulmonary nodules (diameter≤3 cm). * pathologically confirmed as lung adenocarcinoma. * without history of other malignancies. * accurate hematocrit within 1 week before contrast enhanced dual energy CT examination. Exclusion Criteria: * with a history of allergy to iodine contrast agents and other reasons who are unable to complete the examination. * without histopathology of invasion stage, such as AAH, AIS, MIA and IAC. * history of chemotherapy, radiotherapy, or other anti-tumor therapy before contrast enhanced dual energy CT. * poor image quality. * contrast enhanced dual energy CT scans ≥ 4 weeks before surgery.
Conditions3
Adenocarcinoma of LungCancerLung Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorTang-Du Hospital
Started2024-06-01
Est. completion2025-12-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06441357